Sleep and Glycemic Control in Type 2 Diabetes Adolescents

Korábbi kezelés

• Oral or IV steroid treatment within the past month

Más betegség

• Patients with other forms of Diabetes Mellitus (e.g. Type 1 Diabetes)
• Behavioral disorders that may affect data collection (e.g. autism spectrum disorder) will be determined on a case-by-case basis. These include patients that are unable to answer questionnaires on their own, participate in a sleep diary, wear devices and/or understand incentives.
• Subjects with known hyperthyroidism, pain syndrome, or serious medical condition that can affect sleep.
• Known diagnosis of obstructive sleep apnea or other sleep disorder
  • Aim 1 for Parent:
• Parent/guardians with cognitive disorders that may affect data collection (determined on a case-by-case basis)
  • Aim 2 for child:

Laborértékek

• Subjects with hemoglobinopathies that affect hemoglobin A1c measurement.
• Unable to obtain point-of-care hemoglobin A1c in clinic on date of recruitment

Egyéb

• Aim 1 for child:
• Non-English speaking subject (as questionnaires used are validated in English)
• Institutionalized patients as sleep duration will not be of their own accord, and therefore is not generalizable to the rest of the adolescent T2DM population.
• Females with known pregnancies as these patients will not be generalizable to the rest of the adolescent T2DM population and pregnancy may alter sleep duration.
• Non-English speaking subject (as questionnaires used are validated in English)
• Do not own a smart phone or tablet
  • Focus group for child:
• Non-English speaking subject (as focus group will be conducted in English)
• Lack of access to a computer, tablet or smartphone that can accommodate participation in video conferencing

• Aim 1 for child:
• Subjects age 12-20
• Diagnosed with T2DM by standard laboratory criteria without pancreatic autoimmunity
• Low probability of obstructive sleep apnea (OSA) assessed via validated sleep survey
• Subjects will be included if they are taking T2DM treatments (i.e., diet modification, Metformin and/or insulin)
• Parental/guardian permission and child assent
  • Aim 1 for parent:
• Parent or legal guardian of child that meets inclusion criteria for Aim 1.
  • Aim 2 for child:
• Completed Aim 1 evaluation
• Average sleep duration < 8 hours per night as determined by actigraphy in Aim 1
• HbA1c ≤ 10% as HbA1c >10 correlates to poor adherence
• Adherence > 80%
  • Focus group for child:
• Subjects aged 12-20
• Diagnosed with type 2 diabetes without pancreatic autoimmunity